Register
Duloxetine improves joint pain associated with aromatase inhibitor treatment for early-stage breast cancer |
Journal Updates
eMediNexus Coverage from: 
Duloxetine improves joint pain associated with aromatase inhibitor treatment for early-stage breast cancer


comment                   
        



According to a study reported online in the Journal of Clinical Oncology, treatment with duloxetine for aromatase inhibitor-associated musculoskeletal symptoms of joint pain, joint stiffness, functioning was superior to placebo among postmenopausal women with early-stage breast cancer.


Comments

Comments on eMediNexus are moderated. We retain the right to remove any comments at our sole discretion.